Found: 33
Select item for more details and to access through your institution.
Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia: should this be the first choice to establish the diagnosis of APL?
- Published in:
- 2016
- By:
- Publication type:
- Letter
Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 23, p. 6036, doi. 10.3390/ijms20236036
- By:
- Publication type:
- Article
A 4‐gene prognostic index for enhancing acute myeloid leukaemia survival prediction.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2287, doi. 10.1111/bjh.19472
- By:
- Publication type:
- Article
Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01515-w
- By:
- Publication type:
- Article
Bone marrow necrosis as complication of treatment with all-trans retinoic acid and arsenic trioxide: case report and implications for treatment.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Multidimensional radar dot-plots, do we need it for the screening of acute promyelocytic leukemia?
- Published in:
- 2019
- By:
- Publication type:
- Letter
Erratum to: Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Beyond the skin: B cells in pemphigus vulgaris, tolerance and treatment.
- Published in:
- British Journal of Dermatology, 2024, v. 191, n. 2, p. 164, doi. 10.1093/bjd/ljae107
- By:
- Publication type:
- Article
Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-018-08013-z
- By:
- Publication type:
- Article
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2565, doi. 10.3390/cancers14102565
- By:
- Publication type:
- Article
WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1743, doi. 10.3390/cancers11111743
- By:
- Publication type:
- Article
Editorial: Metabolic Rewiring in Leukemias.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620719898373
- By:
- Publication type:
- Article
Detection of the nucleophosmin gene mutations in acute myelogenous leukemia through RT-PCR and polyacrylamide gel electrophoresis.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 1, p. 69, doi. 10.1111/j.1600-0609.2008.01155.x
- By:
- Publication type:
- Article
Evaluation of the prognostic relevance ofl-selectin and ICAM1 expression in myelodysplastic syndromes.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 2, p. 107, doi. 10.1111/j.1600-0609.2007.00986.x
- By:
- Publication type:
- Article
Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes.
- Published in:
- European Journal of Haematology, 2005, v. 75, n. 2, p. 130, doi. 10.1111/j.1600-0609.2005.00426.x
- By:
- Publication type:
- Article
Hepatitis B virus reactivation and alemtuzumab therapy.
- Published in:
- European Journal of Haematology, 2005, v. 74, n. 3, p. 254, doi. 10.1111/j.1600-0609.2004.00375.x
- By:
- Publication type:
- Article
Splenic marginal zone lymphoma with or without villous lymphocytes: Hematologic findings and outcomes in a series of 57 patients.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 9, p. 2050
- By:
- Publication type:
- Article
Diagnostic refinement of chronic myeloproliferative disorders and thrombocytoses of unknown origin by multiple RT-PCR and capillary electrophoresis of BCR-ABL rearrangements and JAK2 (V617F) mutation.
- Published in:
- Annals of Hematology, 2007, v. 86, n. 5, p. 355, doi. 10.1007/s00277-007-0259-9
- By:
- Publication type:
- Article
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00747-w
- By:
- Publication type:
- Article
Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00631-7
- By:
- Publication type:
- Article
Two Cases of Q-Fever in Hairy Cell Leukemia.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01423-7
- By:
- Publication type:
- Article
Identification of a potential 'hotspot' DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
- Published in:
- Genes, Chromosomes & Cancer, 2009, v. 48, n. 3, p. 213, doi. 10.1002/gcc.20633
- By:
- Publication type:
- Article
Galectin-9 Triggers Neutrophil-Mediated Anticancer Immunity.
- Published in:
- Biomedicines, 2022, v. 10, n. 1, p. 66, doi. 10.3390/biomedicines10010066
- By:
- Publication type:
- Article
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107).
- Published in:
- British Journal of Haematology, 2012, v. 156, n. 2, p. 205, doi. 10.1111/j.1365-2141.2011.08940.x
- By:
- Publication type:
- Article
Molecular characterization of paediatric idiopathic hypereosinophilia.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 5, p. 440, doi. 10.1111/j.1365-2141.2010.08394.x
- By:
- Publication type:
- Article
The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2010, v. 149, n. 3, p. 383, doi. 10.1111/j.1365-2141.2010.08098.x
- By:
- Publication type:
- Article
Successful pregnancy after arsenic trioxide therapy for relapsed acute promyelocytic leukaemia.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Prognostic features of splenic lymphoma with villous lymphocytes.
- Published in:
- 2003
- By:
- Publication type:
- Letter
VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00501-x
- By:
- Publication type:
- Article
Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0193098
- By:
- Publication type:
- Article